Signaling mechanisms linking infection, endocrine dysfunction, and growth failure
与感染、内分泌功能障碍和生长障碍相关的信号机制
基本信息
- 批准号:10524772
- 负责人:
- 金额:$ 40.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-15 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsBindingCampylobacterCampylobacter infectionCampylobacter jejuniChIP-seqChildChildhoodChronicChronic Childhood ArthritisComplicationCrohn&aposs diseaseCytokine SignalingDataDiarrheaDiseaseDrosophila genusDrosophila melanogasterEndocrineEndocrine disruptionEndotoxinsEscherichia coliEventExhibitsFailureFat BodyFunctional disorderGenesGeneticGenetic ModelsGenetic ScreeningGenetic TranscriptionGenomic approachGenomicsGrowthGrowth Hormone Signaling PathwayHepatocyteHeterozygoteHomologous GeneHormonesImmuneImmune responseImmune signalingImpaired cognitionImpairmentInfectionInflammationInflammatoryInflammatory Bowel DiseasesInnate Immune SystemInsulin-Like Growth Factor IInterleukinsLaboratoriesLarvaLearning DisabilitiesLinkLiverMammalsMessenger RNAMolecularMusMutationNF-kappa BOrganOrthologous GenePathway interactionsPatientsPreventionPrincipal InvestigatorProductionReceptor SignalingRegulationShigellaSignal PathwaySignal TransductionSiteSomatotropinTLR4 geneTissuesToll-like receptorsTranscriptWorkchronic infectioncognitive developmentcognitive functioncognitive performancecytokineearly childhoodenteric infectionenteric pathogenflyforward geneticsgastrointestinalgenetic approachhormonal signalshormone regulationhormone resistancein vivoinnate immune functioninsulin-like peptideloss of function mutationmodel organismnovel therapeuticspathogenpharmacologicpostnatalpromoterrapid growthreceptorrecruitresponsestemtranscriptomicswhole genome
项目摘要
Infections and inflammatory diseases during childhood cause growth failure. Chronic and simultaneous infection with multiple enteropathogens such as Campylobacter spp. and Escherichia coli is a regular aspect of childhood in many parts of the world. Children suffering from these infections, even when they are asymptomatic for diarrhea, exhibit reduced linear growth. Similarly, children with inflammatory diseases such as juvenile idiopathic arthritis or Crohn's disease are smaller than healthy children. Reduced childhood growth is linked to impaired cognitive function, a complication seen in children with chronic enteropathogen infections and in patients with loss-of-function mutations in the insulin-like growth factor-1 (Igf1) gene. Childhood infections and inflammatory diseases that lead to growth failure are associated with low IGF-1 and elevated growth hormone (GH) levels, indicating GH resistance. However, the signaling events that lead to GH
resistance in response to infection and inflammation are not understood. The principal investigator's
laboratory recently made the discovery that activation of the innate immune Toll signaling pathway in the larval stage of the genetic model organism Drosophila melanogaster leads to growth failure. Reduced growth caused by active Toll signaling stems from a potent reduction in circulating levels of Drosophila insulin-like peptide 6 (Dilp6), the fly homolog of IGF-1. In this application, genomic and genetic approaches in the mouse and the fruit fly will be used to investigate the negative regulation of animal growth by innate immune and inflammatory signaling. In Aim 1, the molecular mechanisms underlying reduced Dilp6 mRNA levels will be investigated. The principal investigator's lab will determine whether Dif, a homolog of NF-kB, binds directly to the Dilp6 promoter to inhibit its expression and will use a forward genetics approach to find additional transcriptional regulators that contribute to the negative regulation of whole-animal growth and/or Dilp6 downstream of Toll signaling. In Aim 2, molecular mechanisms underlying GH resistance during infection will be
investigated. The principal investigator's lab will identify transcriptional mechanisms linking endotoxin and pro-inflammatory cytokine signaling to reduced expression of components of the GH signaling pathway in primary mouse hepatocytes and will use a tissue-specific genetic approach to determine whether MyD88, a common component of the TLR4 and IL-1ß signaling pathways is required in liver to inhibit GH signaling, IGF-1 production and growth in response to Campylobacter infection. Successful completion of the Specific Aims will identify signaling mechanisms underlying a widespread but poorly understood consequence of infection and inflammation: endocrine dysfunction leading to growth failure. The work proposed here will contribute to our understanding of hormone regulation and the control of non-immune functions by innate immune and inflammatory signaling. Furthermore, this work may lead to new therapies for treatment of growth failure and prevention of cognitive impairment in children suffering from chronic infections or inflammatory diseases.
儿童时期的感染和炎症性疾病会导致生长障碍,在世界许多地区,慢性且同时感染多种肠道病原体是这些感染的常见症状,即使他们没有症状。患有炎症性疾病(例如幼年特发性关节炎或克罗恩病)的儿童比健康儿童要小,儿童期生长迟缓与认知能力受损有关。功能障碍是慢性肠道病原体感染儿童和胰岛素样生长因子 1 (Igf1) 基因功能丧失突变患者中常见的一种并发症,导致生长障碍的儿童期感染和炎症性疾病与 IGF 水平低有关。 -1 和生长激素 (GH) 水平升高,表明 GH 抵抗,但导致 GH 的信号事件。
对感染和炎症反应的抵抗力尚不清楚。
实验室最近发现,遗传模型生物果蝇幼虫阶段先天免疫 Toll 信号通路的激活会导致生长障碍,这是由于活跃的 Toll 信号通路引起的生长减慢源于果蝇胰岛素样循环水平的有效降低。肽 6 (Dilp6),IGF-1 的果蝇同源物 在本应用中,将使用小鼠和果蝇的基因组和遗传学方法来研究先天免疫对动物生长的负调节。在目标 1 中,主要研究人员的实验室将研究 Dilp6 mRNA 水平降低的分子机制,以确定 NF-kB 同源物 Dif 是否直接与 Dilp6 启动子结合以抑制其表达。正向遗传学方法寻找有助于整个动物生长和/或 Toll 信号下游 Dilp6 负调节的额外转录调节因子。在目标 2 中,感染期间 GH 抗性的分子机制将是。
首席研究员的实验室将确定内毒素和促炎细胞因子信号转导与原代小鼠肝细胞中 GH 信号转导通路成分表达减少之间的联系,并将使用组织特异性遗传方法来确定 MyD88(一种常见成分)是否存在。肝脏需要 TLR4 和 IL-1ß 信号通路来抑制 GH 信号传导、IGF-1 的产生和生长,以应对弯曲杆菌感染。成功完成特定目标将确定广泛传播的信号传导机制。但对感染和炎症的后果知之甚少:内分泌功能障碍导致生长障碍。这里提出的工作将有助于我们了解先天免疫和炎症信号传导对激素调节和非免疫功能的控制。用于治疗患有慢性感染或炎症性疾病的儿童的生长障碍和预防认知障碍的新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michelle L Bland其他文献
Michelle L Bland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michelle L Bland', 18)}}的其他基金
Signaling mechanisms linking infection, endocrine dysfunction, and growth failure
与感染、内分泌功能障碍和生长障碍相关的信号机制
- 批准号:
10318203 - 财政年份:2020
- 资助金额:
$ 40.38万 - 项目类别:
Identification of novel genes linking inflammation and insulin signaling
鉴定连接炎症和胰岛素信号传导的新基因
- 批准号:
8792845 - 财政年份:2014
- 资助金额:
$ 40.38万 - 项目类别:
Identification of novel genes linking inflammation and insulin signaling
鉴定连接炎症和胰岛素信号传导的新基因
- 批准号:
8562638 - 财政年份:2014
- 资助金额:
$ 40.38万 - 项目类别:
Genetic analysis of AMPK function in Drosophila
果蝇AMPK功能的遗传分析
- 批准号:
6835356 - 财政年份:2004
- 资助金额:
$ 40.38万 - 项目类别:
Genetic analysis of AMPK function in Drosophila
果蝇AMPK功能的遗传分析
- 批准号:
7107225 - 财政年份:2004
- 资助金额:
$ 40.38万 - 项目类别:
Genetic analysis of AMPK function in Drosophila
果蝇AMPK功能的遗传分析
- 批准号:
6962515 - 财政年份:2004
- 资助金额:
$ 40.38万 - 项目类别:
相似国自然基金
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
热带森林土壤氮添加下微节肢动物对氮转化过程的调控
- 批准号:32360323
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
Slc39a13在哺乳动物铁代谢中的作用
- 批准号:32371226
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
乳酸介导的组蛋白乳酸化调控哺乳动物主要合子基因组激活的机制研究
- 批准号:82301880
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
早期环境暴露对儿童哮喘免疫保护的动物实验和机制研究
- 批准号:82300031
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 40.38万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 40.38万 - 项目类别:
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
- 批准号:
10677394 - 财政年份:2023
- 资助金额:
$ 40.38万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 40.38万 - 项目类别:
Illumination of TAAR2 Location, Function and Regulators
TAAR2 位置、功能和调节器的阐明
- 批准号:
10666759 - 财政年份:2023
- 资助金额:
$ 40.38万 - 项目类别: